Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 116 of the 117 references it cites were found in a registry or an index; 9 of the 58 sources its claims cite were checked for support.
Abstract
Alzheimer's disease (AD) is characterized by progressive cognitive decline associated with a featured neuropathology (neuritic plaques and neurofibrillary tangles). Several studies have implicated oxidative damage to DNA, DNA repair, and altered cell-cycle regulation in addition to cell death in AD post-mitotic neurons. However, there is a lack of studies that systematically assess those biological processes in patients with AD neuropathology but with no evidence of cognitive impairment. We evaluated markers of oxidative DNA damage (8-OHdG, H2AX), DNA repair (p53, BRCA1, PTEN), and cell-cycle (Cdk1, Cdk4, Cdk5, Cyclin B1, Cyclin D1, p27Kip1, phospho-Rb and E2F1) through immunohistochemistry and cell death through TUNEL in autopsy hippocampal tissue samples arrayed in a tissue microarray (TMA) composed of three groups: I) "clinical-pathological AD" (CP-AD)--subjects with neuropathological AD (Braak ≥ IV and CERAD = B or C) and clinical dementia (CDR ≥ 2, IQCODE>3.8); II) "pathological AD" (P-AD)--subjects with neuropathological AD (Braak ≥ IV and CERAD = B or C) and without cognitive impairment (CDR 0, IQCODE<3.2); and III) "normal aging" (N)--subjects without neuropathological AD (Braak ≤ II and CERAD 0 or A) and with normal cognitive function (CDR 0, IQCODE<3.2). Our results show that high levels of oxidative DNA damage are present in all groups. However, significant reductions in DNA repair and cell-cycle inhibition markers and increases in cell-cycle progression and cell death markers in subjects with CP-AD were detected when compared to both P-AD and N groups, whereas there were no significant differences in the studied markers between P-AD individuals and N subjects. This study indicates that, even in the setting of pathological AD, healthy cognition may be associated with a preserved repair to DNA damage, cell-cycle regulation, and cell death in post-mitotic neurons.
Overview
CoChat Summary
TL;DR
In autopsy hippocampal tissue, subjects with AD neuropathology and clinical dementia (CP-AD) showed reduced DNA-repair/cell-cycle-inhibition markers and increased cell-cycle-progression and cell-death markers compared with both pathological AD without cognitive impairment (P-AD) and normal aging (N). P-AD subjects were largely indistinguishable from N subjects, suggesting preserved DNA repair and cell-cycle control may accompany resilient cognition despite AD pathology.
Key findings
- Oxidative DNA damage markers were elevated in CP-AD versus N: nuclear 8-OHdG median 25 vs 15 (Dunn p=0.0145) and nuclear H2AX median 20 vs 7 (p=0.0001); high damage was present in all groups.
- Nuclear DNA-repair markers were lower in CP-AD than in P-AD and N: p53 median 7 vs 14 and 15 (CP-AD vs N p<0.0001; CP-AD vs P-AD p=0.0222), and PTEN median 25 vs 31 and 27 (CP-AD vs P-AD p=0.0003; CP-AD vs N p=0.0093).
- Cell-cycle progression markers (Cdk4, cyclin D, phospho-Rb, E2F1, Cdk1, cyclin B) were higher in CP-AD than in P-AD and N, while inhibitors p27 and Cdk5 were lower in CP-AD; apoptosis was higher in CP-AD (median 20) than P-AD (3.5) and N (0).
- Hierarchical clustering separated all CP-AD samples from a combined P-AD + N cluster with 100% bootstrap support; P-AD and N showed no significant differences for the studied markers.
Methods
- Post-mortem hippocampal CA1 tissue from the Brain Bank of the Brazilian Aging Brain Study Group was arrayed in a tissue microarray; groups were CP-AD (neuropathological AD plus dementia), P-AD (neuropathological AD without cognitive impairment), and N (normal aging), with Table 1 listing 19 CP-AD, 12 P-AD, and 31 N subjects (TMA construction text says 18 CP-AD).
- Immunohistochemistry assessed oxidative DNA damage (8-OHdG, H2AX), DNA repair (p53, BRCA1, PTEN, phospho-AKT), and cell-cycle markers (Cdk1, Cdk4, Cdk5, cyclin B1, cyclin D1, p27Kip1, phospho-Rb, E2F1); TUNEL assessed cell death.
- Nuclear and cytoplasmic positivity/intensity were scored semiquantitatively; group comparisons used Kruskal-Wallis with Dunn’s tests, and hierarchical clustering used Pearson correlation with average linkage and bootstrap support.
Limitations
- The paper states that additional studies are required to better understand pathogenic mechanisms, especially early AD stages, and to uncover and validate resilience biomarkers.
- Evident from the text: small group sizes (19 CP-AD, 12 P-AD, 31 N in Table 1), analysis restricted to hippocampal CA1 tissue microarray cores, and semiquantitative manual immunohistochemistry scoring.
- Evident from the text: cross-sectional autopsy design cannot establish causality; the authors argue PMI effects are unlikely because groups did not differ significantly in PMI and intervals were under 24 hours.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
8 Valid · 0 Not valid · 34 Not checked · 56 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Among individuals who showed no overt evidence of cognitive impairment in the final assessment prior to death, post-mortem studies showed a significant proportion of subjects with neuropathological diagnoses of AD”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Introduction
What the sources say
- Not checked yetcites [9] J Price, 1999, Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease, Ann Neurol source
- Supportedcites [10] JL Price, 2009, Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease, Neurobiol Aging source
The Abstract (Results) reports that about 40% of nondemented individuals met some neuropathological criteria for AD, or about 20% under strict criteria, and that neither group had measurable cognitive impairment before death. The Results (Comparison of npAD and no-npAD cases) specifically refer to their last clinical assessment before death. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genes involved in oxidative stress and in DNA damage/repair were found to be coupled with AD neuropathology.”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Introduction
What the sources say
- Supportedcites [24] AR Silva, 2012, Transcriptional alterations related to neuropathology and clinical manifestation of Alzheimer’s disease, PLoS One source
The Abstract states that 'genes involved in energy metabolism, oxidative stress, DNA damage/repair, senescence, and transcriptional regulation were implicated with the neuropathology of AD,' directly matching the claim. The Discussion (AD neuropathology-related gene set) and Results (Gene Expression Profile Related to AD Pathology) reinforce this, listing negative regulation of reactive oxygen species metabolic process and DNA synthesis involved in DNA repair among the overrepresented categories in Braak >=IV / CERAD B-C subjects versus no-pathology controls. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies have reported alterations in DNA repair proteins (cell-cycle checkpoint proteins and tumor suppressors) of pathways involved in the repair of oxidative stress-induced lesions in patients with AD [28], [79].”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Discussion
What the sources say
- Partly supportedcites [28] P Katsel, 2013, Cycle checkpoint abnormalities during dementia: a plausible association with the loss of protection against oxidative stress in Alzheimer’s disease, PLoS One sourceExperimental — accuracy not yet measured
The paper does report alterations in cell-cycle checkpoint proteins and tumor suppressors in AD brain: the Introduction lists prior reports of changed CCL marker expression (including BRCA1, p16, p27, RB) in cortical neurons of persons with AD, and its own Results/Discussion show upregulated MDM4, ATM and ATR with declining TIGAR in STG of AD-dementia cases, described as an activated 'ATM signaling and DNA damage response network'. However, the source's own 'Recent studies have reported' sentence (Abstract > Background) credits checkpoint proteins and tumor suppressors such as ATM and p53 with controlling glycolysis and oxidative metabolism in cancer and states 'their involvement in AD remains uncertain', and the Discussion frames the DNA-damage response as repair of double-strand breaks, with the oxidative-stress link only 'a plausible association' (ATM 'may' link ROS damage to cell-cycle reactivation, loss of TIGAR-mediated protection). So the claim's assertion that these pathways repair oxidative stress-induced lesions in AD patients is presented more firmly than the source, which hedges that connection. (LLM, conf=0.70)
- Not checked yetcites [79] Bucholtz N, Demuth I (2013) DNA-repair in mild cognitive impairment and Alzheimer’s disease. DNA Repair (Amst). source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Yang et al. [34] showed that in brains of people who died with MCI, the percentage of hippocampal neurons positive for cell-cycle proteins (PCNA, cyclin D and cyclin B) was very close to that found in individuals who died in advanced stages of AD (demented).”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Discussion
What the sources say
- Partly supportedcites [34] Y Yang, 2003, Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease, J Neurosci sourceExperimental — accuracy not yet measured
Yang et al. (2003) do report the similarity the claim rests on: the Abstract and the Cell counts section state that in hippocampus the percentages of cell cycle-immunopositive neurons in MCI 'were similar to those found in the AD cases' and far above controls (Table 2: cyclin D 5.2% vs 6.3%, PCNA 7.0% vs 7.1%), and cyclin B 'showed comparable levels of staining in both MCI and AD'. However, the comparison group is not characterized as advanced-stage AD: the Fig. 2 legend describes the AD material as 'subjects who died with mild to moderate AD', and Table 1 shows only 5 of 9 AD cases at Braak V-VI (mean MMSE 18.2, range 3-25), so the 'died in advanced stages of AD' qualifier is not what this source states. Additionally, cyclin B is reported only qualitatively as comparable staining (Fig. 3), not as a tabulated percentage of positive hippocampal neurons like PCNA and cyclin D. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“recent data have suggested a crucial role for Cdk5 as a cell-cycle suppressor in post-mitotic neurons.”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Discussion
What the sources say
- Supportedcites [103] J Zhang, 2010, Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex, J Neurosci source
The INTRODUCTION states outright that 'Cdk5 also plays a crucial role in neuronal cell cycle control,' with loss of Cdk5 causing failure of cell cycle suppression in Cdk5−/− neurons, and frames the work as understanding 'the factors that maintain a mammalian neuron in its post-mitotic state.' The Abstract calls Cdk5 'a potent cell cycle suppressor' and the DISCUSSION reiterates that 'nuclear Cdk5 acts as a cell cycle suppressor both in vivo and in vitro.' The hedged 'recent data have suggested' is therefore supported by a source making the point with equal or greater confidence; the only mild caveat is that the paper's own new experiments are in N2a cells and E14.5 embryonic progenitors, with the post-mitotic-neuron evidence resting on its prior work (Cicero and Herrup, 2005; Zhang et al., 2008) that this paper reports and relies on. (LLM, conf=0.88)
- Not checked yetcites [104] J Zhang, 2012, Cdk5 levels oscillate during the neuronal cell cycle: Cdh1 ubiquitination triggers proteosome-dependent degradation during S-phase, J Biol Chem source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
66 more claims · 1 with their cited sources checked
Create a free account to see all 98 claims and to verify the 49 references still open.
- Probably not a substantial claim. 14
- It may state two separate claims as one. 13
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“elevated phosphorylated histone γH2AX (H2A histone family member X) levels have been reported in the hippocampus and lymphocytes from AD patients, indicating an active DNA damage response [230,231].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [230]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Abstract
“there were no significant differences in the studied markers between P-AD individuals and N subjects.”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Results > Oxidative DNA Damage
“| Cyclin D | 7 (0–14) | 9 (0–15) | 0 (0–15) | 0.0072* | 0.3813 | 0.269 | 0.0056* |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Tissue Samples and Neuropathological/Cognitive Assessment
“| N1 | M | 80 | 3 | 0 | 0 | 19.7 |”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Tissue Samples and Neuropathological/Cognitive Assessment
“31 subjects without neuropathological AD (Braak≤II and CERAD 0 or A) and with normal cognitive function”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Women, n (%) | 16 (84.2) | 7 (61.5) | 16 (51.6) | 0.064b |”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Results
Reported 61.5 · recomputed 58.333333
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“hippocampal samples (CA1 region) from 62 subjects (18 CP-AD, 12 P-AD, and 31 N)”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Construction of Tissue Microarray
Reported 62 · recomputed 61
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Tissue Samples and Neuropathological/Cognitive Assessment
“| CP-AD1 | F | 98 | 3 | B | 2 | 15.1 |”
§ Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease > Materials and Methods > Tissue Samples and Neuropathological/Cognitive Assessment
“19 subjects with neuropathological AD (Braak≥IV and CERAD = B or C) and clinical dementia”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
1 retracted
BRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496 · cited 1×
“Among the studied biomarkers, BRCA1 is associated with a spectrum of functions related to the preservation of genome stability, such as the repair of oxidative damage to DNA [84,85].”
BackgroundRetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“Neurofibrillary tangles (NFTs) and neuritic plaques (NPs) were assessed by a skilled neuropathologist in accordance with the Braak stage system [55] and the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) [56], respectively.”
MethodThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 1×
“Notably, phosphorylated Akt may enhance cell survival by blocking the function of proteins and apoptotic processes [95].”
BackgroundGlobal prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“Alzheimer’s disease (AD) is the most frequent cause of dementia in the elderly, accounting for approximately 70% of dementia cases [1,2].”
BackgroundMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 4×
“Based on pathological and clinical criteria, subjects were categorized into three groups: I) 19 subjects with neuropathological AD (Braak$IV and CERAD=B or C) and clinical dementia (CDR$2, IQCODE.3.8), termed ‘‘clinical-pathological AD’’ (CPAD); II) 12 subjects with neuropathological AD (Braak$IV and CERAD=B or C) and…”
MethodInfluentialTM4: a free, open-source system for microarray data management and analysis
Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., et al. (2003) · BioTechniques · doi:10.2144/03342mt01 · Cited by 4,837
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Cited by
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“Moreover, elevated phosphorylated histone γH2AX (H2A histone family member X) levels have been reported in the hippocampus and lymphocytes from AD patients, indicating an active DNA damage response [230,231].”
BackgroundMicroglial/Macrophage Polarization Dynamics following Traumatic Brain Injury
Kumar, A., Alvarez-Croda, D.-M., Stoica, B. A., Faden, A. I., & Loane, D. J. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4268 · Cited by 339
“inhibition, we assessed H2AX expression in the peri-lesional cortex, which is a marker of oxidative stress-induced DNA damage.(25)”
MethodFragile X-associated tremor/ataxia syndrome — features, mechanisms and management
Hagerman, R. J., & Hagerman, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.82 · Cited by 290
Cellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice
Suberbielle, E., Djukic, B., Evans, M., Kim, D. H., Taneja, P., Wang, X., Finucane, M., Knox, J., Ho, K., Devidze, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9897 · Cited by 202
“2c), consistent with previous reports 13,14 .”
Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis
Kandimalla, R., & Reddy, P. H. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.018 · Cited by 144
Fragile X syndrome and associated disorders: Clinical aspects and pathology
Salcedo‐Arellano, M. J., Dufour, B. D., McLennan, Y. A., Martínez‐Cerdeño, V., & Hagerman, R. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104740 · Cited by 160
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01012-6 · Cited by 140
“even more so in clinical-pathological AD brain [103].”
BackgroundContributions of DNA Damage to Alzheimer’s Disease
Lin, X., Kapoor, A., Gu, Y., Chow, M. J., Peng, J., Zhao, K., & Tang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051666 · Cited by 117
Redox Signaling in Neurotransmission and Cognition During Aging
Kumar, A., Yegla, B., & Foster, T. C. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7111 · Cited by 109
“Finally, for neurodegenerative diseases, levels of oxidative damage are increased above age-matched controls (253, 267).”
BackgroundXu, P., Liu, Q., Xie, Y., Shi, X., Li, Y., Peng, M., Guo, H., Sun, R., Li, J., Hong, Y., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.06.012 · Cited by 100
Vázquez-Villaseñor, I., Garwood, C. J., Heath, P. R., Simpson, J. E., Ince, P. G., & Wharton, S. B. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12559 · Cited by 87
Tao, Y., Han, Y., Yu, L., Wang, Q., Leng, S. X., & Zhang, H. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00233 · Cited by 98
“Oxidative stress can cause transiton of cell cycle from the stationary G0 phase to irregular DNA replication and mitosis by causing DNA damage in neurons (42), which leads to tau overphosphorylation and aggregation into NFTs probably (43).”
Backgroundde Vries, L. E., Huitinga, I., Kessels, H. W. H. G., Swaab, D. F., & Verhaagen, J. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00719-7 · Cited by 92
The Response to Oxidative DNA Damage in Neurons: Mechanisms and Disease
Narciso, L., Parlanti, E., Racaniello, M., Simonelli, V., Cardinale, A., Merlo, D., & Dogliotti, E. (2016) · Neural Plasticity · doi:10.1155/2016/3619274 · Cited by 84
The impact of base excision DNA repair in age-related neurodegenerative diseases
Leandro, G. S., Sykora, P., & Bohr, V. A. (2015) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2014.12.011 · Cited by 72
Leandro, G. D. S., Evangelista, A. F., Lôbo, R. R., Xavier, D. J., Moriguti, J. C., & Sakamoto‐Hojo, E. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170205 · Cited by 81
Jørgensen, A., Baago, I. B., Rygner, Z., Jørgensen, M. B., Andersen, P. K., Kessing, L. V., & Poulsen, H. E. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2066 · Cited by 70
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 83
Zinc in Cognitive Impairment and Aging
Sun, R., Wang, J., Feng, J., & Cao, B. (2022) · Biomolecules · doi:10.3390/biom12071000 · Cited by 81
Foret, M. K., Orciani, C., Welikovitch, L. A., Huang, C., Cuello, A. C., & Carmo, S. D. (2024) · Communications Biology · doi:10.1038/s42003-024-06552-4 · Cited by 66
“Thiscontrasts withtheincreasedlevelsofoxidativelymodi fi ed neuronal DNA previously reported in post-mortem material from individuals with DS 93 , pre-clinical AD (PCAD) 94,95 , MCI 96 , and AD 97 – 102 .”
van Leeuwen, L. A. G., & Hoozemans, J. J. M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1382-7 · Cited by 73
“We next put forward that with disease progression, the building up of oxidative stress, genotoxic insults and deterioration of DNA repair mechanisms lead to the accumulation of DSB lesions, which have been found to be increased in AD patients [20, 88], eventually to an extent that is no longer repairable.”
BackgroundAbate, G., Frisoni, G., Bourdon, J., Piccirella, S., Memo, M., & Uberti, D. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00732-0 · Cited by 56
Regulator of Cell Cycle (RGCC) Expression during the Progression of Alzheimer's Disease
Counts, S., & Mufson, E. J. (2017) · Cell Transplantation · doi:10.3727/096368916x694184 · Cited by 60
Oxidative Stress and Aberrant Cell Cycle in Alzheimer’s Disease Lymphocytes: Diagnostic Prospects
Wojsiat, J., Prandelli, C., Laskowska-Kaszub, K., Martín‐Requero, Á., & Wojda, U. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141977 · Cited by 60
The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration
Konopka, A., & Atkin, J. D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.836885 · Cited by 58
Altered DNA repair; an early pathogenic pathway in Alzheimer’s disease and obesity
Yu, H., Harrison, F. E., & Xia, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-23644-4 · Cited by 51
The Phosphorylated Form of the Histone H2AX (γH2AX) in the Brain from Embryonic Life to Old Age
Merighi, A., Gionchiglia, N., Granato, A., & Lossi, L. (2021) · Molecules · doi:10.3390/molecules26237198 · Cited by 58
Zolochevska, O., & Taglialatela, G. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160518142110 · Cited by 49
“DNA repair proteins (P53, BRCA1 and PTEN) were significantly elevated in control and NDAN when compared to AD, which indicates the DNA repair pathway is a possible compensatory mechanism in NDAN allowing these individuals to maintain proper cognitive functioning and, therefore, resist memory impairment [30].”
BackgroundResultInfluentialDNA damage and its links to neuronal aging and degeneration
Delint‐Ramírez, I., & Madabhushi, R. (2025) · Neuron · doi:10.1016/j.neuron.2024.12.001 · Cited by 63
Aberrant Accumulation of BRCA1 in Alzheimer Disease and Other Tauopathies
Nakamura, M., Kaneko, S., Dickson, D. W., & Kusaka, H. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz107 · Cited by 51
Huang, J.-L., Jing, X., Tian, X., Qin, M.-C., Xu, Z., Wu, D., & Zhong, Z.-G. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8713561 · Cited by 43
“It has been reported that 8-OHdG, which is the most commonly analyzed biomarker of oxidative damage to DNA, showed higher levels in the brains of AD patients than in subjects with normal aging [20].”
BackgroundPostsynaptic Proteome of Non-Demented Individuals with Alzheimer’s Disease Neuropathology
Zolochevska, O., Bjorklund, N., Woltjer, R., Wiktorowicz, J. E., & Taglialatela, G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180179 · Cited by 42
Tramutola, A., Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., Butterfield, D. A., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151105 · Cited by 40
“p53 is activated in response to a wide variety of stresses that can damage the cell genome; once it is bound to sites of DNA damage, p53 promotes DNA repairandsimultaneouslystimulatesthetranscriptionofdirecteffectorsofcell-cyclearrest[29].”
Brokaw, D. L., Piras, I. S., Mastroeni, D., Weisenberger, D. J., Nolz, J., Delvaux, E., Serrano, G. E., Beach, T. G., Huentelman, M. J., & Coleman, P. D. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.022 · Cited by 49
“Evidence suggests that apoptosis is heightened in AD brains (Albrecht et al., 2009; Selznick et al., 1999; Silva et al., 2014; Stadelmann et al., 1999; Su et al., 2001; Troncoso et al., 1996).”
InfluentialMolecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
Lee, H.-J., Yoon, Y.-S., & Lee, S.-J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168114 · Cited by 36
Exploring Genetic Outcomes as Frailty Biomarkers
Valdiglesias, V., Sánchez-Flores, M., Marcos-Pérez, D., Lorenzo‐López, L., Maseda, A., Millán-Calentí, J. C., Pásaro, E., & Laffón, B. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly085 · Cited by 35
“Silva and colleagues (43) also reported an increase in γH2AX nuclear expression levels in individuals with Alzheimer’s disease with regard to healthy individuals, and we previously found that the presence of cognitive impairment and frailty was independently related to an increase in the frequency of micronuclei in ly…”
BackgroundDNA damage and neurodegenerative phenotypes in aged Ciz1 null mice
Khan, M. M., Xiao, J., Patel, D., & LeDoux, M. S. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.014 · Cited by 43
“The presence of extensive DNA damage and neuroinflammation in the aged brain may be manifestations of defective DNA repair pathways and accumulative oxidative damage to DNA (Silva et al., 2014, Chen et al., 2010).”
BackgroundMicroenvironment-Cell Nucleus Relationship in the Context of Oxidative Stress
Chittiboyina, S., Bai, Y., & Lelièvre, S. A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00023 · Cited by 38
“Beyond oxidative DNA damage induced by hydroxyl radicals that is not necessarily associated with disease development (Evans et al., 2004; Silva et al., 2014; Pereira et al., 2016), ROS might influence transcription depending on their concentration and origin.”
BackgroundWang, X., Hu, X., Yang, Y., Takata, T., & Sakurai, T. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.06.008 · Cited by 38
MAPT (Tau) expression is a biomarker for an increased rate of survival for low‑grade glioma
Zaman, S., Chobrutskiy, B. I., Sikaria, D., & Blanck, G. (2018) · Oncology Reports · doi:10.3892/or.2018.6896 · Cited by 42
Chwastek, J., Jantas, D., & Lasoń, W. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.03.015 · Cited by 33
Functional variants identify sex-specific genes and pathways in Alzheimer’s Disease
Bourquard, T., Lee, K. D., Al‐Ramahi, I., Pham, M., Shapiro, D., Lagisetty, Y., Soleimani, S., Mota, S., Wilhelm, K. O., Samieinasab, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38374-z · Cited by 36
Aging and Alzheimer’s disease connection: Nuclear Tau and lamin A
Gil, L., Niño, S. A., Capdeville, G., & Jiménez-Capdeville, M. E. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135741 · Cited by 31
An Adaptive Role for DNA Double-Strand Breaks in Hippocampus-Dependent Learning and Memory
Boutros, S. W., Unni, V. K., & Raber, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158352 · Cited by 31
U1 snRNP Alteration and Neuronal Cell Cycle Reentry in Alzheimer Disease
Bai, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00075 · Cited by 28
Kumar, A., Kalita, J., Sinha, R. A., Singh, G., Anjum, B., Shukla, M., Tiwari, S., Dhole, T. N., & Misra, U. K. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03080-5 · Cited by 28
Bourgois, A., Saurat, D., Araujo, S. D., Boyard, A., Guitard, N., Renault, S., Fargeau, F., Frédéric, C., Peyret, E., Emmanuel Flahaut, B., et al. (2021) · Inhalation Toxicology · doi:10.1080/08958378.2021.1996492 · Cited by 25
“As previously shown, NPs inhalation could also initiate increased production of enzymes such as endonuclease III homolog 1 (NTH1) or apurinic/apyrimidinic endonuclease 1 (APE1) (Ma et al. 2013), p53 (Silva et al. 2014), or poly [ADP-ribose] polymerase 1 (PARP-1) (Qin et al. 2008), involved in various repair mechanisms…”
BackgroundInfluentialKoleck, T. A., Bender, C., Clark, B. Z., Ryan, C. M., Ghotkar, P., Brufsky, A., McAuliffe, P. F., Rastogi, P., Sereika, S. M., & Conley, Y. P. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s123785 · Cited by 29
“In addition, cyclin B levels were reported to be upregulated in autopsy hippocampal tissue in individuals with neuropathological Alzheimer’s disease and clinical dementia compared to individuals with normal aging.(65) Nevertheless, the consistency of findings across three variants all theorized to impact expression in…”
Methylation analysis of DNA repair genes in Alzheimer’s disease
Coppedè, F., Tannorella, P., Stoccoro, A., Chico, L., Siciliano, G., Bonuccelli, U., & Migliore, L. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.003 · Cited by 24
Siddiqui, M. S., Francois, M., Hecker, J., Faunt, J., Fenech, M. F., & Leifert, W. R. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.03.001 · Cited by 20
Vázquez-Villaseñor, I., Garwood, C. J., Simpson, J. E., Heath, P. R., Mortiboys, H., & Wharton, S. B. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15466 · Cited by 18
“…pathologies has also been shown to induce sustained activation of DDR signalling, which could initially be activated in order to promote repair, but that could become faulty or detrimental with chronicity (Barrio-Alonso et al., 2018; Kim et al., 2020; Silva et al., 2014; Simpson et al., 2015).”
BackgroundPiccirella, S., Neste, L. V., Fowler, C., Masters, C. L., Fripp, J., Doecke, J. D., Xiong, C., Uberti, D. L., & Kinnon, P. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.52 · Cited by 17
The UFMylation pathway is impaired in Alzheimer’s disease
Yan, T., Heckman, M. G., Craver, E. C., Liu, C., Rawlinson, B. D., Wang, X., Murray, M. E., Dickson, D. W., Ertekin‐Taner, N., Lou, Z., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00784-y · Cited by 25
Fanni, D., Gerosa, C., Rais, M., Ravarino, A., Eyken, P. V., Fanos, V., & Faa, G. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.063 · Cited by 18
Frailty syndrome, biomarkers and environmental factors – A pilot study
Gomes, A., Lage, B., Esteves, F., Sousa, A. C. A., Pastorinho, M. R., Valdiglesias, V., Costa, S., Laffón, B., & Teixeira, J. P. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.04.023 · Cited by 16
Age- and Nicotine-Associated Gene Expression Changes in the Hippocampus of APP/PS1 Mice
Yang, J., Long, Y., Xu, D., Zhu, B., Deng, X., Yan, Z., Sun, F., & Chen, G.-J. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01389-7 · Cited by 16
Cell cycle deregulation in neurodegenerative diseases
Zhang, X., Song, S., & Peng, W. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1924705 · Cited by 15
“[41] said that p27Kip1 decreased in AD brains than normal brains.”
BackgroundRanganathan, R., Sapozhnikov, G., Wang, N., Li, S., & Song, Y. (2023) · Translational Medicine of Aging · doi:10.1016/j.tma.2023.06.004 · Cited by 14
Cho, S. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042211 · Cited by 12
“Downregulation of BRCA1 and other DNA repair genes has been observed in patients with clinically evident AD [56].”
BackgroundKumar, S., Paul, A., Kalita, S., Ghosh, A. K., Mandal, B., & Mondal, A. C. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12912 · Cited by 15
Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair
Leung, E., & Hazrati, L. (2021) · Brain Communications · doi:10.1093/braincomms/fcab117 · Cited by 16
“Alzheimer’s disease subjects with both cognitive impairment and Alzheimer’s disease pathology showed higher expression of markers indicative of early and late cell cycle stages, lower expression of cell cycle inhibitors, and elevated rates of apoptotic neurons compared to subjects with only disease pathology and contr…”
BackgroundResultInfluentialTang, F. R., Liu, L., Wang, H., Ho, K. J. N., & Sethi, G. (2021) · Aging · doi:10.18632/aging.203202 · Cited by 13
“astrocyte [9] and neuronal [83] nuclei, but also in blood lymphocytes of AD patients, suggesting that lymphocyte γH2AX levels may be used to identify population with a high risk of AD development [84].”
BackgroundPetrović, N., Essack, M., Sami, A. S., Perry, G. L., Gojobori, T., Isenović, E. R., & Bajić, V. (2023) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2023.107925 · Cited by 13
Dnmt1-dependent Chk1 pathway suppression is protective against neuron division
Oshikawa, M., Okada, K., Tabata, H., Nagata, K., & Ajioka, I. (2017) · Development · doi:10.1242/dev.154013 · Cited by 13
“…inactivation on the differentiation and survival of cortical neurons Rb phosphorylation, which causes cell-cycle re-entry and subsequent cell death, plays an important role in the progression of neuronal disorders (Biswas et al., 2007; Nguyen et al., 2003; Silva et al., 2014; Yu et al., 2012).”
BackgroundInfluentialYaghoobi, A., & Malekpour, S. A. (2024) · BMC Genomics · doi:10.1186/s12864-024-10363-6 · Cited by 10
Kartha, S., Weisshaar, C. L., Pietrofesa, R. A., Christofidou‐Solomidou, M., & Winkelstein, B. A. (2020) · Antioxidants · doi:10.3390/antiox9121209 · Cited by 10
“Chronic loss of redox homeostasis also leads to neuronal DNA damage, which has been increasingly linked to neurodegenerative diseases including Alzheimer’s and Parkinson’s disease [17,18], and more recently to radicular pain [17].”
BackgroundTranscriptional Regulation Analysis of Alzheimer's Disease Based on FastNCA Algorithm
Sun, Q., Kong, W., Mou, X., & Wang, S. (2019) · Current Bioinformatics · doi:10.2174/1574893614666190919150411 · Cited by 10
Tsamou, M., Pistollato, F., & Roggen, E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201418 · Cited by 9
Boutros, S. W., Zimmerman, B., Nagy, S. C., Unni, V. K., & Raber, J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01966-8 · Cited by 11
“Hippocampal 8-Hydroxydeoxyguanosine is higher, while 53BP1 and PTEN (another DNA repair protein) are decreased in post-mortem tissue from diagnosed AD patients, suggesting impaired DSB repair [95].”
BackgroundCucoș, C. A., Milanesi, E., Dobre, M., Musat, I. A., Manda, G., & Cuadrado, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105799 · Cited by 9
“Moreover, oxidative DNA damage [20,21] in the AD brain, tightly connected with Aβ and TAU pathologies [12], seem to occur prior to disease onset [22,23].”
BackgroundBiological response modifiers. Interferons, interleukins, and transfer factor.
Kirkpatrick, C. H. (1989) · PubMed · Cited by 10
Biomaterial-engineering and neurobiological approaches for regenerating the injured cerebral cortex
Ajioka, I. (2016) · Regenerative Therapy · doi:10.1016/j.reth.2016.02.002 · Cited by 8
“Moreover, Rb phosphorylation is correlated with the cell-cycle reentry of pathological neurons [47,48] and the progression of AD [49,50].”
BackgroundKouhnavardi, S., Cabatic, M., Mañas‐Padilla, M. C., Malabanan, M.-A., Smani, T., Cicvaric, A., Aranzalez, E. M., Koenig, X., Urban, E., Lübec, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119565 · Cited by 8
Siddiqui, M., François, M., Rainey‐Smith, S. R., Martins, R. N., Masters, C. L., Ames, D. J., Rowe, C. C., Macaulay, L. S., Fenech, M. F., & Leifert, W. R. (2020) · Life · doi:10.3390/life10080141 · Cited by 9
“A number of studies have been conducted to assess the association between astrocyte degeneration and DNA damage in AD by investigating the γH2AX signals in astrocytes from the hippocampal region [46,47].”
BackgroundResultÁvila, J., Gómez‐Ramos, A., & Soriano, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00323 · Cited by 8
“In this regard, impaired repair of oxidative DNA damage may influence the clinical manifestation of AD (Silva et al., 2014).”
BackgroundDing, L., Ning, J., Wang, Q., Lu, B., & Ke, H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119111 · Cited by 5
RetractedThe UFMylation pathway is impaired in Alzheimer’s diseasePreprint
Yan, T., Heckman, M. G., Craver, E. C., Liu, C., Rawlinson, B. D., Wang, X., Murray, M. E., Dickson, D. W., Ertekin‐Taner, N., Lou, Z., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.24.595755 · Cited by 5
The many connections of UFMylation with Alzheimer’s disease: a comprehensive review
Yan, T., Clarkson, B. D. S., Lou, Z., Springer, W., & Fiesel, F. C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00855-8 · Cited by 5
“…of γH2AX signal, increased levels of the other DNA damage sensors such as 53BP1, and phospho-Ser1981 ATM (p-ATM) have also been reported [6, 79, 80, 91], although total levels of ATM and MRN proteins seem reduced in AD cortical neurons, which could further contribute to the accumulation of DNA…”
Some problems and errors in cytogenetic biodosimetry
Mosse, I. B., Kilchevsky, A. V., Nikolova, N., & Zhelev, N. (2016) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2016.1259018 · Cited by 4
Piccirella, S., Uberti, D. L., Xiong, C., Fowler, C. J., Doecke, J. D., Fagan, A. M., Frisoni, G. B., & Kinnon, P. (2021) · Preprints.org · doi:10.20944/preprints202105.0267.v1 · Cited by 4
“Aβ: amyloid beta; AIBL: Australian Imaging, Biomarkers, and Lifestyle; AUC: area under the receiver operating characteristic curve; AD: Alzheimer’s disease; APOE ε4: apolipoprotein E ε4 allele; BACE1: β-site amyloid precursor protein-cleaving enzyme 1; CI: confidence interval; CN: cognitively normal; CSF: cerebrospina…”
BackgroundThe role of DNA damage and repair in toxicity to postmitotic cells caused by cancer therapies
Vasko, M. R., Shariati, B., & Zanville, N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803582-5.00013-9 · Cited by 2
Heat Shock Protein 70 and Molecular Confession During Neurodegeneration
Panchal, K., Kumar, A., & Tiwari, A. K. (2018) · Heat shock proteins · doi:10.1007/978-3-319-89551-2_1 · Cited by 3
Kuninaka, Y., Ishida, Y., Grimaldi, F., Irmici, M., Nosaka, M., Munekawa, M., Pelotti, S., Fais, P., & Kondo, T. (2026) · Scientific Reports · doi:10.1038/s41598-026-38797-w · Cited by 1
Petkova, R., Chelenkova, P., Tournev, I., & Chakarov, S. (2016) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2016.1179593 · Cited by 1
“[55] Increased levels of 8-OHdG (8-hydroxo-2'-deoxyguanosine) and H2AX (a variant of the core histone H2A, one of the earliest damage-signalling molecules) were found in brains of elderly (85 years of age) patients with AD as well as in age-matched controls without cognitive decline, but the levels of damage in the AD…”
BackgroundLeandro, G. D. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2017.tde-04012017-141718
SIÇANLARDA KARBON TERAKLORÜR İLE UYARILMIŞ BEYİN HASARINDA Morus nigra’ NIN KORUYUCU MEKANİZMASI
Deniz, G. Y. (2017) · Mehmet Akif Ersoy Üniversitesi Veteriner Fakültesi Dergisi · doi:10.24880/maeuvfd.341661
Vázquez-Villaseñor, I. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
The Effect of Bilateral Salpingo-Oophorectomy on Cognition in Women Prior to Natural Menopause
Au, A. (2018) · TSpace (University of Toronto) · Cited by 1
Ono, R. M. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-10042023-084601
Alzheimer’s Disease: Link to Aging and Epigenetics
Zala, D. K., Banerjee, S., & Tiwari, A. K. (2025) · RNA technologies · doi:10.1007/978-3-031-91072-2_15 · Cited by 1
Camilo, C., Vieira, L. M., Gouveia, G. R., Torrezan, A. C., Peixoto, A., Euclydes, V. L. V., Francisco, R. P. V., Brentani, A., Felipe-Silva, A., & Brentani, H. (2025) · Biology Methods and Protocols · doi:10.1093/biomethods/bpaf056 · Cited by 1
Self-citationFarmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Figshare · doi:10.6084/m9.figshare.12788590
Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Figshare · doi:10.6084/m9.figshare.12788593
Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Figshare · doi:10.6084/m9.figshare.12788602
Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Figshare · doi:10.6084/m9.figshare.12788596
Yaghoobi, A., & Malekpour, S. A. (2024) · Figshare · doi:10.6084/m9.figshare.26715724
Barros, T. G. R., Grossi, L. B., Campos, M. L. D. S., Cardoso, I. B.-H. N., Teixeira, A. L., de Miranda, A. S., & Toscano, E. C. D. B. (2026) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70077
Avanesyan, H., Parsadanyan, M. A., Shahinyan, M. A., Багдасарович, Л. А., Mikaelyan, M. S., Grigoryan, S. V., & Vardevanyan, P. O. (2025) · Neurophysiology · doi:10.1007/s11062-026-10001-9
“Therefore, from the presentation of the above-mentioned material, we can insist on the fact that neurodegeneration is a multifactorial process and in the certain cases, it can be expressed as apoptosis of the specific group of neurons [186–188].”
Kumar, D., Shee, S., Datusalia, A. K., & Sharma, S. S. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.07.003
Metadata
- Authors
- Silva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., de Bragança Pereira, C. A., Jacob-Filho, W., & Brentani, H.
- Affiliations
- Universidade de São Paulo (BR)
- AC Camargo Hospital (BR)
- Corresponding author
- Silva, Aderbal R. T.
- Grinberg, Lea T.
- Rocha, Rafael M.
- Carraro, Dirce M.
- Brentani, Helena
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-17
- Volume
- 9
- Issue
- 6
- Pages
- e99897
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4061071
- OpenAlex
- W2129162505
- Cited by
- 99
- References
- 117
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 15 · 2019: 4 · 2018: 13 · 2017: 9 · 2016: 11 · 2015: 7 · 2014: 1
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (11/01652-6, 2011/)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- Alzheimer's disease, oxidative DNA damage, DNA repair, cell cycle regulation, neuronal cell death, postmitotic neurons, hippocampus, 8-hydroxy-2'-deoxyguanosine, H2AX, p53, BRCA1, PTEN, cyclins, cyclin-dependent kinases, p27, E2F1, normal aging
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Cell Cycle, DNA Damage, DNA Repair, Female, Hippocampus, Humans, Male, Neurons, Apoptosis, Oxidative Stress, Tissue Array Analysis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.